Active Ingredient History

NOW
  • Now
Pentobarbital is a short-acting barbiturate typically used as a sedative, a preanesthetic, and to control convulsions in emergencies. It can also be used for short-term treatment of insomnia but has been largely replaced by the benzodiazepine family of drugs.   Wikipedia
Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort
  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial Organizations: 10

  • SMILES: CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
  • InChIKey: WEXRUCMBJFQVBZ-UHFFFAOYSA-N
  • Mol. Weight: 226.28
  • ALogP: 1.18
More Chemistry
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral, Parenteral, Topical
  • Pro Drug: No

Drug Pricing (per unit)

United States

$22.0302 - $45.1255
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5-ethyl-5-(1-methylbutyl)-2,4,6(1h,3h,5h)-pyrimidinetrione | 5-ethyl-5-(1-methylbutyl)barbituric acid | 5-ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione | 5-ethyl-5-(sec-pentyl)barbituric acid | beuthanasia | ethaminal | euthanase | euthatal | mebubarbital | mebumal | nembutal | nembutal sodium | neodorm | pentabarbitone | pentobarbital | pentobarbital calcium | pentobarbital sodium | pentobarbitone | pentobarbitone sodium | pentobarbituric acid | phetobarbitone | sagatal | sodium pentobarbital

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue